INJECTABLE BONE GRAFT AND ALLOGRAFT BONE CHIPS IN THE TREATMENT OF BENIGN BONE LESION
Journal: International Journal of Advanced Research (Vol.11, No. 07)Publication Date: 2023.8.4
Authors : Abdulrahman Hisham Bobseit Turki Bandar Alotaibi Muteb Saad Alqhtani Faisal Eid Nazal Alanazi Abdulhadi Jameel Alotaibi; Abdullah A. Alhamdan;
Page : 1001-1008
Keywords : ;
Abstract
This study aimed to compare the efficacy of injectable bone grafts and allograft bone chips in the treatment of benign bone lesions. A total of 34 patients were included, with varying types and locations of lesions. The results showed no significant differences between the two groups in terms of age, gender, lesions type, diagnosis, site of the lesion, and bone leakage. However, the remodelling time was significantly shorter in the injectables group (5+3 months) than in the bone chips group (12+5 months). This study contributes to the understanding of the benefits and limitations of different bone grafting techniques for the treatment of benign bone lesions.
Other Latest Articles
- An Exploration of the Concept of Identity Crisis in Salman Rushdie’s Grimus
- Internalized Homophobia in Ocean Vuong’s on Earth we’re Briefly Gorgeous
- The catastrophe of blazing forests, hills in flame and the failing British during 1916-1921
- Dissociation Energy of an (O2) Oxygen Molecule by DFT Calculations |Biomedgrid
- How Simultaneous Using of Photo Biomodulation and Natural Killer Cells is Effective in Treatment of Cancer? |Biomedgrid
Last modified: 2023-09-01 15:33:03